These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

382 related articles for article (PubMed ID: 35197077)

  • 21. Prevalence and Significance of Non-conventional Antiphospholipid Antibodies in Patients With Clinical APS Criteria.
    Litvinova E; Darnige L; Kirilovsky A; Burnel Y; de Luna G; Dragon-Durey MA
    Front Immunol; 2018; 9():2971. PubMed ID: 30619328
    [No Abstract]   [Full Text] [Related]  

  • 22. The challenges in diagnosing pediatric primary antiphospholipid syndrome.
    Demir S; Keskin A; Sağ E; Kaya Akca Ü; Atalay E; Cüceoğlu MK; Batu Akal ED; Özen S; Bilginer Y
    Lupus; 2022 Sep; 31(10):1269-1275. PubMed ID: 35746827
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Antiphospholipid syndrome nephropathy in patients with systemic lupus erythematosus and antiphospholipid antibodies: prevalence, clinical associations, and long-term outcome.
    Tektonidou MG; Sotsiou F; Nakopoulou L; Vlachoyiannopoulos PG; Moutsopoulos HM
    Arthritis Rheum; 2004 Aug; 50(8):2569-79. PubMed ID: 15334471
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Performance validation of the 2023 American College of Rheumatology/European League Against Rheumatism antiphospholipid syndrome classification criteria in an antiphospholipid syndrome cohort.
    Zhao Y; Huang C; Zhou Y; Qi W; Cai B; Hu C; Song Y; Zhu T; Shi X; Liu X; Wang Q; Tian X; Zhao Y; Zeng X; Li M; Zhao J
    J Thromb Haemost; 2024 Jun; 22(6):1660-1674. PubMed ID: 38462219
    [TBL] [Abstract][Full Text] [Related]  

  • 25. [Case series and clinical analysis of 14 cases of catastrophic antiphospholipid syndrome].
    Gu JY; Lu C; Shi H; Yang CD
    Beijing Da Xue Xue Bao Yi Xue Ban; 2018 Dec; 50(6):1033-1038. PubMed ID: 30562777
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Anti-prothrombin (aPT) and anti-phosphatidylserine/prothrombin (aPS/PT) antibodies and the risk of thrombosis in the antiphospholipid syndrome. A systematic review.
    Sciascia S; Sanna G; Murru V; Roccatello D; Khamashta MA; Bertolaccini ML
    Thromb Haemost; 2014 Feb; 111(2):354-64. PubMed ID: 24172938
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Anti-Phosphatidylserine/Prothrombin Antibodies at Two Points: Correlation With Lupus Anticoagulant and Thrombotic Risk.
    Egri N; Bentow C; Rubio L; Norman GL; López-Sañudo S; Mahler M; Pérez-Isidro A; Cervera R; Viñas O; Espinosa G; Ruiz-Ortiz E
    Front Immunol; 2021; 12():754469. PubMed ID: 34790198
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Antiphospholipid antibody tests: spreading the net.
    Bertolaccini ML; Gomez S; Pareja JF; Theodoridou A; Sanna G; Hughes GR; Khamashta MA
    Ann Rheum Dis; 2005 Nov; 64(11):1639-43. PubMed ID: 15817655
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Identification of rare anti-phospholipid/protein co-factor autoantibodies in patients with systemic lupus erythematosus.
    Szodoray P; Tarr T; Tumpek J; Kappelmayer J; Lakos G; Poor G; Szegedi G; Kiss E
    Autoimmunity; 2009 Sep; 42(6):497-506. PubMed ID: 19626489
    [TBL] [Abstract][Full Text] [Related]  

  • 30. A retrospective review of antiphospholipid syndrome: a single tertiary centre experience.
    Yeoh WC; Lim AL
    Med J Malaysia; 2024 May; 79(3):306-312. PubMed ID: 38817063
    [TBL] [Abstract][Full Text] [Related]  

  • 31. [Clinical significance of antiphospholipid antibody in pediatric patients and review of literature].
    Xiao HJ; Yang JY; Gao TJ; Huang JP; Yao Y; Zhang Y
    Zhonghua Er Ke Za Zhi; 2004 Aug; 42(8):571-3. PubMed ID: 15347440
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Circulating immune-complexes of IgG/IgM bound to B2-glycoprotein-I associated with complement consumption and thrombocytopenia in antiphospholipid syndrome.
    Naranjo L; Stojanovich L; Djokovic A; Andreoli L; Tincani A; Maślińska M; Sciascia S; Infantino M; Garcinuño S; Kostyra-Grabczak K; Manfredi M; Regola F; Stanisavljevic N; Milanovic M; Saponjski J; Roccatello D; Cecchi I; Radin M; Benucci M; Pleguezuelo D; Serrano M; Shoenfeld Y; Serrano A
    Front Immunol; 2022; 13():957201. PubMed ID: 36172349
    [TBL] [Abstract][Full Text] [Related]  

  • 33. The Diagnostic Value of New Additional Antiphospholipid Antibodies in Antiphospholipid Syndrome.
    Khogeer H; Altahan S; Alrehaily A; Sheikh A; Awartani K; Al-Kaff M; Saleh S; Alzahrani H; Alfattani A; Owaidah T
    Ann Clin Lab Sci; 2021 Jul; 51(4):552-556. PubMed ID: 34452895
    [TBL] [Abstract][Full Text] [Related]  

  • 34. [Primary antiphospholipid syndrome].
    Popa A; Voinea L; Pop M; Stana D; Dascalu AM; Alexandrescu C; Ciuluvica R
    Oftalmologia; 2008; 52(1):13-7. PubMed ID: 18714484
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Antiphospholipid antibodies in pediatrics.
    Quintero-Del-Rio AI
    Curr Rheumatol Rep; 2002 Oct; 4(5):387-91. PubMed ID: 12217242
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Childhood-onset systemic lupus erythematosus-related antiphospholipid syndrome: A multicenter study with 1519 patients.
    Islabão AG; Mota LMH; Ribeiro MCM; Arabi TM; Cividatti GN; Queiroz LB; Andrade DC; Sakamoto AP; Trindade VC; Novak GV; Molinari BC; Campos LM; Aikawa NE; Pereira RMR; Terreri MT; Magalhães CS; Marini R; Gomes HR; Silva MF; Oliveira SK; Sztajnbok FR; Sacchetti SB; Bica BE; Sena EG; Moraes AP; Santos MC; Robazzi TC; Spelling PF; Scheibel IM; Cavalcanti AS; Naka EN; Guimarães LJ; Santos FP; Sampaio MC; Bonfá E; Silva CA;
    Autoimmun Rev; 2020 Dec; 19(12):102693. PubMed ID: 33164791
    [TBL] [Abstract][Full Text] [Related]  

  • 37. [Antiphospholipid syndrome (APS) primary (PAPS) and secondary (SAPS)].
    Chwalińska-Sadowska H; Meissner M; Wudarski M; Zabek J; Wojciechowska B
    Pol Arch Med Wewn; 2006 May; 115(5):401-6. PubMed ID: 17195351
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Validation of the adjusted global antiphospholipid syndrome score in systemic lupus erythematosus patients in Argentina.
    Garcia L; Velloso MS; Martire MV; Savy F; Arizpe F; Garcia N; Testi A; Pena C; Costi AC; Isnardi C; Capelusnik D; Mazza S; Curi YS; Collado V; Rodriguez MF; Scarafia S; Pisoni C; de la Torre M; Seewald A; Riva ME; Garcia M
    Lupus; 2020 Dec; 29(14):1866-1872. PubMed ID: 33028177
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Hughes syndrome and epilepsy: when to test for antiphospholipid antibodies?
    Noureldine MH; Harifi G; Berjawi A; Haydar AA; Nader M; Elnawar R; Sweid A; Al Saleh J; Khamashta MA; Uthman I
    Lupus; 2016 Nov; 25(13):1397-1411. PubMed ID: 27225212
    [TBL] [Abstract][Full Text] [Related]  

  • 40. [Systemic lupus erythematosus and antiphospholipid syndrome - diagnostic and therapeutic problems].
    Zdrojewski Z
    Wiad Lek; 2018; 71(1 pt 1):40-46. PubMed ID: 29558350
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 20.